?Aris Global, a provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT? (inbound receipt and triage) 6.0
Aris Global Expands Its Electronic Exchange Platform
with Release of agXchange IRT™ 6.0
Advanced software solution increases ability to report complete and accurate safety case information on time
AT THE DIA CONFERENCE (Boston, MA) - June 23, 2008: Aris Global, a leading provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT™ (inbound receipt and triage) 6.0, a Web-based, solution for securely and efficiently receiving adverse event information, in different formats, from affiliates, co-development partners, consumers, healthcare providers, investigator sites, CROs, and other stakeholders.
During the DIA 44th Annual Meeting, Aris Global will be demonstrating and presenting agXchange IRT in its booth #834 in the Boston Convention and Exhibition Center.
agXchange IRT is the newest module of the agXchange™ gateway for extended electronic exchange, which also includes agXchange ESM™, an electronic submissions module that supports the import and export of adverse event data in E2B and extended E2B formats. agXchange IRT allows organizations to more closely integrate their affiliate offices into the processes of collecting and submitting safety information even if they do not have access to the central drug safety system. Comprehensive assessment and triage capabilities allow organizations to assess incoming potential safety items prior to case processing.
“Aris Global is committed to the extended electronic exchange gateway as the way organizations can take advantage of the inherent productivity benefits that automated paperless operations deliver,” said Wim Cypers, vice president, product management, Aris Global. “The agXchange IRT module will decrease the amount of time organizations spend collecting and verifying safety information, and will increase their ability to report complete and accurate safety information on time.”
About Aris Global
Aris Global (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 direct and indirect life science customers rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
# # #
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.